Resolution Rx Ltd

ResolutionRx is repurposing with an improved formulation and strong data, an FDA approved drug, dronabinol, for Obstructive Sleep Apnea, a poorly treated patient population with multiple co-morbidities and no available drugs. This is a risk reduced, efficient strategy targeting approximately 90 million patients in the US, UK, Germany and Australia and 936 million worldwide.